Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Familial amyloidosis classification
Introduction
Overview
Overview
Familiar amyloidosis may be classified according to the type of mutant protein into 7 subtypes: Transthyretin (TTR), apolipoprotein AI, cystatin C, lysozyme, fibrinogen A alpha-chain, gelsolin, and apolipoprotein AII.
Classification
Classification
Familial amyloidosis may be classified according to the type of mutant protein into 7 subtypes:[1][2][3]
- Transthyretin (TTR)
- Apolipoprotein AI
- Apolipoprotein AII
- Fibrinogen Aa
- Lysozyme
- Gelsolin
- Cystatin C
 |  |  |  |  |  |  |  |  |  |  |  |  | Genes involved in familial amyloidosis |  |  |  |  |  |  |  |  |  |  |  | |||||||||||||||||||||||||||||||||
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | ||||||||||||||||||||||||||
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | |||||||||||||||||||||||||||
 | Transthyretin (TTR) |  | Apolipoprotein AI |  | Gelsolin |  | Lysozyme |  | Cystatin C |  | Fibrinogen Aa-chain |  | Apolipoprotein AII | ||||||||||||||||||||||||||||||||||||||||||||
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | |||||||||||||||||||||||
 | Mutations: • Asp18Glu • Leu55Gln • Asp18Gly • His56Arg • Asp18Asn • Leu58His • Val20Ile • Leu58Arg • Ser23Asn • Thr59Lys • Pro24Ser • Thr60Ala • Ala25Ser • Glu61Lys • Ala25Thr |  | Mutations: • Gly26Arg • Leu60Arg • Trp50Arg • del60-71 • del70-72 • Leu75Pro • Leu90Pro • Arg173Pro • Leu174Ser • Leu178His |  | Mutations: •Asp187Asn •Asp187Tyr |  | Mutations: • Ile56Thr • Asp67His • Trp64Arg • Phe57Ile |  | Mutation: • Leu68Gln |  | Mutations: • Arg554Leu • Glu526Val • 4904delG • 4897delT |  | Mutations: • stop78Gly • stop78Ser • stop78Arg | ||||||||||||||||||||||||||||||||||||||||||||
 | • Cys10Arg • Leu55Pro • Leu12Pro • Leu55Arg • Phe64Leu • Val28Met • Phe64Ser • Val30Met • Ile68Leu • Val30Ala • Tyr69His • Val30Leu • Tyr69Ile • Val30Gly • Lys70Asn • Phe33Ile • Val71Ala • Phe33Leu • Ile73Val • Phe33Val • Ser77Tyr • Phe33Cys • Ser77Phe • Arg34Thr • Tyr78Phe • Lys35Asn • Ala81Thr • Ala36Pro • Ile84Ser |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | |||||||||||||||||||||||||||||||||
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | ||||||||||||||||||||||||||||||
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | ||||||||||||||||||||||||||||||
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | ||||||||||||||||||||||||||||||
References
References
- ↑ Benson, Merrill D (2003). “The hereditary amyloidoses”. Best Practice & Research Clinical Rheumatology. 17 (6): 909–927. doi:10.1016/j.berh.2003.09.001. ISSN 1521-6942.
- ↑ Benson, Merrill D (2003). “The hereditary amyloidoses”. Best Practice & Research Clinical Rheumatology. 17 (6): 909–927. doi:10.1016/j.berh.2003.09.001. ISSN 1521-6942.
- ↑ Scriver, Charles (2001). The metabolic & molecular bases of inherited disease. New York: McGraw-Hill. ISBN 978-0079130358.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.